Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.
Join Women in Bio's RTP Chapter on December 10 for its End-of-Year Celebration—a special evening for women to connect, celebrate achievements, and enjoy meaningful networking. Additionally, Pepper ...
In this interactive workshop, designed for small business owners and managers, you’ll discover key drivers of employee engagement, learn cost-effective strategies, and create a personalized engagement ...